Table 4. Multivariable cox regression analysis of DFS and OS for patients with breast cancer.
| Parameter | Disease-free survival | Overall survival | ||
|---|---|---|---|---|
| HR (95% CI) | P-value | HR (95% CI) | P-value | |
| Stage | ||||
| II vs I | 1.37 (0.34–5.67) | 0.790 | 1.94 (0.98-3.83) | 0.354 |
| III vs II | 2.21 (1.64–3.69) | 0.015 | 1.70 (1.32–2.64) | 0.025 |
| PVI present | 4.78 (2.28–7.65) | 0.000 | 5.34 (3.41–9.36) | 0.001 |
| PR positive | 0.36 (0.28–0.73) | 0.018 | 0.41 (0.17–0.86) | 0.023 |
| Platelet, n | - | - | 1.85 (1.58–3.67) | 0.034 |
| High-sensitivity C-reactive protein, mg/l | 1.87 (1.29–4.61) | 0.003 | 2.15 (1.67–5.31) | 0.014 |
| RDW, % | 1.89 (1.28–3.62) | 0.000 | 2.43 (1.62–3.21) | 0.024 |